Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Similar documents
Cryptogenic Strokes: Evaluation and Management

Alan Barber. Professor of Clinical Neurology University of Auckland

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

CEREBRO VASCULAR ACCIDENTS

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

2015 Update in Diagnosis and Management of Stroke

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Management and Investigation of Ischemic Stroke By Etiology

2018 Early Management of Acute Ischemic Stroke Guidelines Update

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

2018 Update in Diagnosis and Management of Stroke

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Acute Stroke Protocols Modified- What s New in 2013

Cryptogenic Stroke: A logical approach to a common clinical problem

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Emergency Treatment of Ischemic Stroke

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

Alan Barber. Professor of Clinical Neurology University of Auckland

Comparison of Five Major Recent Endovascular Treatment Trials

2014 Update in Diagnosis and Management of Stroke

Speakers. 2015, American Heart Association 1

Practical Considerations in the Early Treatment of Acute Stroke

Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Secondary Stroke Prevention: A Precautionary Tale

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

PATIENT S NOTES History and Physical Brain Attack Stroke

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Management of Atrial Fibrillation. Leon Ptaszek, MD, PhD, FACC, FHRS 25 March 2018

STROKE UPDATE ANTHEA PARRY MAY 2010

Primary Stroke Center Quality & Performance Measures

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy

TIA: Updates and Management 2008

PFO Management update

Long-Term Care Updates

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

OHSU HEALTH CARE SYSTEM PRACTICE GUIDELINES

Stroke Guidelines. November 19, 2011

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

William Barr, M.D. January 28, 2017

Dawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego

Case 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE

GERIATRICS CASE PRESENTATION

How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval

OHSU Health Care System

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

La gestione dell ictus ischemico o emorragico nel paziente sotto NAO

Stroke, Stroke, Stroke Where Do We Stop on the River? Comprehensive vs. Primary Stroke Centers


ACCESS CENTER:

The Importance of Stroke Programs in an Acute Care Setting by Debbie Estes, RN, BSN Stroke Program Coordinator, Medical City of Dallas

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

How to Evaluate Patients with Cryptogenic Stroke

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Preoperative Management of Patients Receiving Antithrombotics

Stroke ESO.org. Csiba László.

Emergency Department Management of Acute Ischemic Stroke

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Advances in Neuro-Endovascular Care for Acute Stroke

Endovascular Treatment Updates in Stroke Care

Objectives. Stroke Facts 2/27/2015. EMS in Stroke Care: A Critical Partnership

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

Diagnosis: Allergies with reaction type:

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Shands at the University of Florida Stroke Program

True cryptogenic stroke

Stroke/TIA. Tom Bedwell

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

KPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending

Stroke Awareness. Presented by: Duane Anderson, MD Snoqualmie Valley Hospital Emergency Department Medical Director

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Primary Prevention of Stroke

Latest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G

New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.1

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Transcription:

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco I have no financial disclosures 1

Hospital Management Thrombolytic and Thrombectomy Blood pressure Stroke in the Young Large vessel stroke Cardio-embolic stroke Antiplatelet Anticoagulation Prevention of complications Stroke Clinic Management issues Cryptogenic stroke Risk factor modification Post-Stroke Depression 1 in every 20 deaths in the US 20% increase in prevalence by 2030 3.4 million more people over the age of 18 57% of stroke mortality is outside a hospital 2

Age-adjusted death rates for stroke by sex and race/ethnicity, 2011. Dariush Mozaffarian et al. Circulation. 2015;131:e29-e322 Copyright American Heart Association, Inc. All rights reserved. IV rtpa is the standard therapy if < 3 hours NNT is 3 for improved outcome Every 15 minute reduction in DTN = 5% improved in hospital mortality < 1/3 of patients had DTN times < 60 minutes. 3

Normal/near normal = NNT 8.3 Improved = NNT 3.1 For 100 patients treated with tpa 32 benefit and 3 harmed 3 4.5 hrs (not FDA approved) but 16% more have good outcome Lancet 2004;363:768-74. 4

Blood Pressure < 185/110 Hemorrhage risk (ICH, SAH, AVM, Neoplasm) Bleeding diathesis (INR, heparin, platelets) Recent Surgery Hypoglycemia Head trauma or stroke in last 3 months > 1/3 hemispheric infarct on CT Minor Seizure Minor deficits MI within 3 months Pregnancy 5

Not FDA approved but is supported by guidelines Trial exclusion criteria Age >80 Baseline NIHSS >25 Any oral anticoagulant Previous stroke and diabetes Suggest some attempt at obtaining consent Recanalization Rate: ICA terminus 4.4% M1 32.3 % Basilar 4% 6

MR CLEAN stent retriever up to 6 hours 32.6% versus 19.1% independent; OR 1.67 ESCAPE trial stent retriever up to 12 hours 53% versus 29.3% independent; Ratio 1.8 EXTEND IA - 71% versus 40% SWIFT PRIME 60% vs 35% OR 2.75 NEJM. 2015; 372:11-20 NEJM. 2015; 372:1019-30 NEJM 2015; 372:1009-18 NEJM 2015; April 17 Epub ahead of print 7

Initial ED Evaluation within 10 minutes Notify stroke team within 15 minutes of arrival CT scan within 25 minutes Read on CT within 45 minutes IV tpa within 60 minutes Thrombectomy for proximal vessels in < 6 hrs Other studies: glucose, O2 sat, BMP, CBC, cardiac enzymes, INR/PT/PTT, EKG. Stroke. 2013;44:870-947 65.8% of the American population has access within 60 minutes to a primary stroke center. 63.1% had access to comprehensive stroke centers Triage directly to primary stroke centers is advised. Rural stroke patient 10 times less likely to receive tpa than urban primary stroke center. Neurology. 2015;84:1196-205 Telemed J E Health. 2012;18:230-237 8

Stroke Ambulances: Time to treatment is reduced by 41 minutes Drip and Ship agreements between hospitals Tele-neurology/stroke evaluation remotely Lancet Neurol. 2012;11:397-404 Analysis of 12 telestroke networks had 23%thrombolysis rate 10-fold increase from baseline AHA recommends telestroke if on-site stroke expertise is insufficient for 24/7 coverage Class I, Level A 18% lower risk of a poor outcome with telestroke. Stroke 2009;40:902-8. Neurology 2011;77:1590-8. 9

LOC: Responsiveness, Questions, Commands Eye Movement Visual fields Facial Palsy Motor Arm : left and right Motor Leg: left and right Ataxia Sensory Language Speech Extinction and inattention Minor is 1-4 Moderate 5-15 Moderate to severe 16-20 Severe 21-42 Stroke patient decompensates Decompressive craniotomy Class I, B NNT 2 mortality, NNT 4 to be ambulatory Advanced age and patient/family values may change this Evaluate for EVD 10

ICU for frequent Neuro and Vital Sign monitoring Every 15 minutes for 2 hours Every 30 minutes for 6 hours Every 1 hour until 24 hours post tpa Stop tpa if severe HA, worsening exam BP goal < 180/105 No heparin products, anti-platelets for 24 hours Obtain HCT or MRI in 12-24 hrs Avoid or delay invasive procedures (NG, Foley) NPO unless passes swallow screen Aspirin 325mg or 300mg rectal if no NG or NPO Permissive blood pressure < 220/120 for 48 hours Can consider ICU vs Medical/Stroke Unit with telemetry based on clinical scenario Lovenox for DVT prophylaxis NG if fails formal speech evaluation 11

PT/OT/Speech - Early mobilization Euthermia Euglycemia. Goal glucose 100-200 Cholesterol panel. Fasting glucose or A1C. Stroke education of risk factors and treatment Smoking cessation, diet and exercise Avoid Foleys or minimize use < 24 hours What is the etiology: Artery-to-artery embolism (carotid disease) Cardio-embolic (atrial fibrillation) Small vessel disease (diabetes, hypertension) Hypercoagulable Cryptogenic 12

Increasing proportion of ischemic stroke patients Etiology: dissections, cardioembolism, thrombophilias CT or MR angiogram of the neck vessels If TTE is negative then TEE with bubble study Lupus anticoagulant, anticardiolipin, HC, MTHFR, toxins Lumbar puncture in suspected vasculitis patients Carotid Ultrasound if anterior circulation, TCD for intracranial stenosis CT or MR angiogram head and neck Echocardiogram Telemetry 13

>70% stenosis or 50-69% stenosis on ipsilateral side of infarct Confirm ultrasound with CT or MR angiogram Cerebral angiogram if acute occlusion. If >70% stenosis confirmed or critical stenosis but not occlusion then endarterectomy within 2 weeks High risk of recurrent stroke WASID warfarin versus aspirin SAMMPRIS 20.9% vs 12.9% (stroke and death) VISSIT 36.2% vs 15.1% (stroke and TIA) EC/IC Bypass Study surgery vs aspirin 44% vs 23.7% NEJM 2005;352:1305. Lancet 2014;383:333-341. NEJM 1985;313:1191-1200. JAMA 2015;313:1240-1248 14

Hypertension: Permissive hypertension < 220/110 if no rtpa < 180/105 if rtpa given frequent measurements Lower by 15% - U shaped curve Avoid venodilators (nitro, hydralazine) Diuretic and ACE-I preferred 12 point reduction in BP reduces stroke by 37% Goal < 140/90, perhaps < 130 systolic for lacunar Stroke. 2013;44:870-947 Stroke. 2014;45:2160-236 Acutely atorvastatin 80mg Goal is LDL-C is < 100 Diabetic patient goal LDL-C is < 70 Follow up liver function in 6 weeks Each 10% LDL reduction reduced risk of stroke by 15.6% Stroke 2014;45:2160-236 NEJM 2006;355:549-59 15

% Coronary Surface Covered 5/22/2015 1% reduction in HbA1C decreased hazard ratio by 21% Reasonable goal of A1C < 7. 90 60 30 0 30 40 50 60 70 80 Age Plasma Cholesterol Level of 200 mg/dl (5.17 mmol/l) Grundy SM, JAMA 1986 Estimated 10-year stroke risk in adults 55 years of age according to levels of various risk factors (Framingham Heart Study). Dariush Mozaffarian et al. Circulation. 2015;131:e29-e322 Copyright American Heart Association, Inc. All rights reserved. 16

Aspirin (15% RR) - acutely 325mg daily Clopidogrel - 75mg daily Dipyridamole-aspirin twice daily Clopidogrel and dipyridamole-aspirin are superior to aspirin and non-inferior to each other CHANCE trial - clopidogrel and aspirin for 90 days NEJM 2013;369:12-19 At least 15% of ischemic stroke. Anti-coagulate about 1 2 weeks post large territory infarct. Consider sooner if small infarcts or mechanical heart valve. No heparin bridging required 17

Score 1 = > 95% sensitivity for predicting stroke Circulation.2012;126:860-865 Warfarin INR goal 2-3, only 60% are in range Dabigatran - 150mg twice daily Superior to warfarin in RE-LY study. Major bleeding same, but less intracranial bleeds Apixaban 5mg twice daily Superior to warfarin in ARISTOTLE study. Fewer major bleeding events and lower mortality Rivaroxaban- 20mg daily Non-inferior to warfarin in ROCKET-AF trial No difference in bleeding and less intracranial bleeds NEJM. 2009;361:1139-1151; NEJM. 2011:365:981-992; NEJM. 2011;365: 883-891 18

Warfarin Rheumatic heart disease Cardiac thrombus Thrombophilias Mechanical heart valves Dissection of vertebral or carotid artery LMWH Neoplasm related hypercoagability Pregnant women Avoid if MRI evidence of amyloid angiopathy Stroke education Medication education Smoking cessation Holter ideally 30 days Alert family to signs of decompensation and poststroke depression Rehab arrangements 19

1/3 of patients discontinued >1 medications within 1 year 2/3 of Medicare patients who had a stroke died or were rehospitalized within 1 year Never seen by a neurologist Communication lacking from the inpatient to rehabilitation to outpatient primary physician Stroke 2011;42:159-66. Neurology 2011;77:1182-1190 Cryptogenic stroke: 1/3 rd of ischemic strokes CRYSTAL AF study 12.4% vs 2% in 12 months TEE range of value 2-20% detect a lesion TCD with emboli detection Pulmonary shunting Occult neoplasm evaluation CADASIL, infection, vasculitis NEJM 2014;370:2478-86 Am Heart J 2014;168:706-12 20

PFO was not associated with increased risk Meta-analysis showed no benefit of closure Aortic Arch Atheroma - >4 mm Aortic Stenosis Mitral valve disease Myxoma and thrombus Stroke 2014;45:3352-9. Can J Cardiol 2014;30:1216-24 50 75% of stroke or TIA patients 7% had central sleep apnea Poor prediction with Epworth Sleepiness Scale Poorer outcomes with mortality, delirium,, functional status, depressed mood CPAP use NNT was 4.9 Stroke. 2014;45:2160-236. Eur Respir J 2012:39:906-912 21

About 1/3 rd of stroke patients suffer depression PTSD in 29.6% of patients after TIA Double the risk of suicide (male, young, severe) Higher Mortality 3.4 times for another event Increased cognitive impairments Stroke 2014;45:3360-6. Neurology 2015 April 1. Lancet Neurology 2011;10:123-30 22

Age - 60 = 1 Blood pressure = 1 Speech impaired = 1 Weakness = 2 10-59 minutes = 1 60 minutes = 2 Diabetes = 1 2 day stroke risk: 0-3 = 1% 4 5 = 4.1% 6-7 = 8.1 % Lancet 2007;369:283-292 23